🔎 Trials Near Me

Utama › Kanser Salur Bilier › Texas › Houston

Kajian klinikal Kanser Salur Bilier di Houston, TX

18 kajian untuk Kanser Salur Bilier sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Mengambil pesertaFasa 2
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Mengambil pesertaFasa 2
  • Research Site, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06219941

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07221253

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Mengambil pesertaFasa 1/2
  • University of Texas MD Anderson Cancer Center ( Site 0316), Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06428409

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Mengambil pesertaFasa 2
  • Research Site, Houston
Umur 18 hingga 130 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05489211

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Mengambil pesertaFasa 1
  • Oncology Consultants, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

Mengambil pesertaFasa 1/2
  • MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06548412

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Houston
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • MD Anderson, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06774963

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Mengambil pesertaFasa 3
  • Research Site, Houston
Umur 18 hingga 99 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT06467357

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Mengambil pesertaFasa 2
  • University of Texas MD Anderson Cancer Center, Houston
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Mengambil pesertaFasa 1
  • The University of Texas MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07458347

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Mengambil pesertaFasa 1
  • The University of Texas MD Anderson Cancer Center, Houston
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT07197554

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06239194

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Mengambil pesertaFasa 2
  • Houston Methodist Hospital Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Apr 2026 · NCT05733598

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Dis 2025 · NCT06943521

Kajian Kanser Salur Bilier di bandar lain

Kajian lain di Houston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.